134 related articles for article (PubMed ID: 2454363)
1. Antihypertensive compounds with combined actions.
Rahn KH
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S18-22. PubMed ID: 2454363
[TBL] [Abstract][Full Text] [Related]
2. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Strein K; Sponer G
Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with dual-acting drugs in hypertension.
Rahn KH
Clin Investig; 1992; 70 Suppl 1():S39-42. PubMed ID: 1350483
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of multiple action compounds.
Prichard BN; Tomlinson B
Z Kardiol; 1989; 78 Suppl 3():1-6. PubMed ID: 2573211
[TBL] [Abstract][Full Text] [Related]
7. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
Bakris G
J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
9. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
Abshagen U
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
[TBL] [Abstract][Full Text] [Related]
10. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
12. Influence of salt intake on the antihypertensive effect of carvedilol.
Ruilope LM; Lahera V
J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
[TBL] [Abstract][Full Text] [Related]
13. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
14. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
Lund-Johansen P
Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
Hara Y; Nakahara H; Miyagishi A; Nakatani H
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
[TBL] [Abstract][Full Text] [Related]
16. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
Tanaka M; Masumura H; Tanaka S; Akashi A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368
[TBL] [Abstract][Full Text] [Related]
17. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
Moser M; Frishman W
Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mode of vasodilating action of carvedilol.
Sponer G; Strein K; Müller-Beckmann B; Bartsch W
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
[TBL] [Abstract][Full Text] [Related]
20. Clinical and hemodynamic effects of celiprolol in essential hypertension.
Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
